In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Studying Depression at a Molecular Level
Psychiatric Times
How do defective neuro-glia interactions contribute to depression? A recent study suggests that alterations in astrocyte metabolism is a major hallmark of depression. In this Mental Health Minute, Michal Slezak, PhD, explains how he and other researchers used state-of-the-art imaging techniques and genetic approaches to identify molecular processes impaired in depression.
J&J taps BioMed X for crowdsourced oral biologics delivery push
FiercePharma
Johnson & Johnson has teamed up with BioMed X Institute to advance oral delivery of monoclonal antibodies and other biologics. The initiative will support the work of a small team that will work to identify ways to get large molecules across the intestinal epithelial barrier.
El Instituto BioMed X inicia un nuevo proyecto de investigación sobre administración de fármacos en colaboración con Janssen
FarmaIndustrial
El instituto de investigación independiente alemán BioMed X anuncia su nuevo proyecto de investigación con Janssen Research & Development, una de las compañías farmacéuticas Janssen de Johnson & Johnson, que se esforzará por descubrir nuevos mecanismos de transporte en el tracto intestinal humano que podrían utilizarse para la administración oral de diversas modalidades terapéuticas.
Crowdsourcing and open innovation in drug discovery: recent contributions and future directions
Drug Discovery Today
The past decade has seen significant growth in the use of ‘crowdsourcing’ and open innovation approaches to engage ‘citizen scientists’ to perform novel scientific research. Here, we quantify and summarize the current state of adoption of open innovation by major pharmaceutical companies.
Germany-based BioMed X Institute completed its first joint research project in neuroscience with Boehringer Ingelheim.
BioSpace
Following completion of the project, the research has now transitioned to BI for additional development. The team has validated candidate genes in several biological systems, and as a key achievement, proposes novel glial-specific drug targets for therapy of depression.
The Biomed X Institute, of Heidelberg, Germany, said it completed its first joint research neuroscience project with Boehringer Ingelheim GmbH, of Ingelheim, Germany.
BioWorld
The project launched in 2016 to uncover the contribution of astrocytes, a subtype of glial cells, to molecular phenotypes in depression.
Talenten auf der Spur
DER SPIEGEL, special section 'Starkes Land Baden-Württemberg' (print edition for Baden Württemberg)
Careers in the industry: The region around Heidelberg attracts top-class specialists from all over the world with quality of life, a lively international atmosphere and a wide range of jobs in research and industry. (German only)
Biotech in Deutschland – eine Branche weit unter Potenzial
BioSpektrum
Als bedeutender Forschungszweig in der Medizin liefert die Biotechnologie wichtige Impulse für neue Wirkstoffe, Medikamente und Diagnostika. Trotz des großen Innovationspotenzials in Deutsch land liegen hier die Investitionen in die Translation von Forschungsergebnissen in marktfähige Produkte weit hinter den internationalen Spitzenstandorten Silicon valley und Boston.